FDA Inspection 1018168 — Children's Hospital Los Angeles

Children's Hospital Los Angeles — FEI 2016501

The FDA completed an inspection of Children's Hospital Los Angeles on May 18, 2017 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)